A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX®

This study has been terminated.

( Slow recruitment; Study did not address safety concern raised by European Medicines Agency )

Study NCT00034788 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: May 2, 2002 Last Updated: July 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2004
Estimated Primary Completion Date:	No date given